COVID-19, and its disproportionate effect on minority populations highlighted the need for increased diversity in clinical trials in order to adequately treat every patient population. The biopharma industry has resisted diversification in the past because its infrastructure breeds success in working within non-diverse populations. However, 2020, changed things, and the urgency to improve diversification is now higher than ever. Companies must begin to shift focus to include more minority populations to ensure that clinical trial representation is increased moving forward.
It seems like a no-brainer. If a company wants to treat everyone who has a certain disease with its new drug, then it should test that drug in, well, everyone.
MVG Consulting Services specializes in helping small to medium sized biotechnology and pharmaceutical companies with their clinical development programs and we can provide start-up and virtual companies with the necessary resources to begin their clinical development program.
Services include:
- Clinical Research Consulting Services
- Clinical Trial Development
- Project Rescue
- Inspection Readiness
MVG provides highly qualified clinical research professionals who seamlessly become a part of your project team. Additionally, we provide virtual companies with an entire project team that encompasses all aspects of clinical development.
We invite you to fill out the form below to learn more about how MVG Consulting can help you with your clinical devleopment needs.
